Cas9 immunity creates challenges for CRISPR gene editing therapies
Abstract Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a genome-editing technology1,2 that utilizes archaeal and bacterial Cas9 nucleases to introduce double-stranded breaks in DNA at targeted sites. These breaks can be used to remove, replace, or add pieces of DNA. Whil...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e6e102c06f9f4413a3b861226fafa27a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|